Barrington analyst Michael Petusky maintained a Buy rating on Varian Medical Systems (VAR) today and set a price target of $142. The company’s shares opened today at $127.87.
Petusky observed:
“We have slightly reduced our FY/19 non-GAAP EPS estimate to $4.61 from $4.62 previously.”
According to TipRanks.com, Petusky is a 4-star analyst with an average return of 5.0% and a 54.7% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Merit Medical Systems, and DENTSPLY SIRONA Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Varian Medical Systems with a $149 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $142.50 and a one-year low of $101.42. Currently, Varian Medical Systems has an average volume of 515.9K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments.
